menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Michelle Krausz
Rick Turner
Biopharmaceutical medicines bring tremendous benefit to millions of patients worldwide. However, it is an unfortunate but immutable fact that no biologically active drug is free from the possibility of causing adverse reactions in certain individuals who are genetically and/or environmentally susceptible. Drugs for cardiac diseases or conditions of clinical concern are expected to affect the heart, having a mechanism of action that brings therapeutic benefit via advantageous changes to a patient’s biology and physiology. Drugs for all other diseases, i.e., non-cardiac drugs, are not intended to affect the heart, but it is extremely important that appropriate investigations are conducted during its development to ensure that a new drug will not have an unacceptable risk of cardiac side...
Read More
TonyaBroyles
Any number of factors can complicate patients’ decisions about the benefits and risks of their medications, but a good CNE will set the record straight.
Read More
Sandy Kennedy
How an effective quality management system can help sponsors save time, money and safely bring new drugs to market faster.
Read More
Olga Uspenskaya-Cadoz
Anke van Engen
Developers pursing accelerated pathways should work with payers to understand what evidence needs to be obtained to increase the chance of a positive recommendation.
Read More
PeterLassoff
Regulatory professionals will explore the shifting global regulatory environment and how it’s changing our roles at the annual Regulatory Affairs Professionals Society (RAPS) conference.
Read More
Zia H.
Maximizing the value of real-world research through the proper data management strategy.
Read More
Volker-Ronicke
Bringing treatment to patients earlier by de-risking therapeutic intervention.
Read More
Nimita Limaye
Risk-based monitoring can add considerable benefits to the research environment, but companies need help figuring out how to implement these programs and track results.
Read More